DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
7 articles
CAR T therapy, one of modern oncologyās most aggressive tools, is now being tested in autoimmune disease, where the target is no longer a tumor but an immune system attacking its own body.
A Phase 3 cancer vaccine trialās undisclosed ānarrow failureā last August erased IO Biotechās $127M IPO and forced a Tuesday SEC bankruptcy filing.
MSKCC's in vivo CAR-T trial shows promise for 5 myeloma patients.
Keratinocytes in the epidermis donāt just detect threatsāthey broadcast them via a newly identified pathway, Chinese researchers revealed in *Nature Immunology* this week.
mRNA cancer vaccines show promise but face years of trialsāprogress isnāt the same as proven therapy.
East Asian men with a missing Y chromosome in their pancreatic cells face 30% higher diabetes oddsā*but only if their genetic risk is otherwise low*, per a *Nature Medicine* analysis of 200,000+ genomes.
A new study published in Nature Biotechnology has developed a generative modeling framework that enables petascale synthesis of designed DNA, with a DOI of 10.1038/s41587-026-03020-8.
